Advertisement

Picture Sino Biological Symposium Antibody Engineering Leipzig 650x100px
Organisation › Details

AstraZeneca plc (LSE: AZN)

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. *

 

Period Start 1999-04-05 merged
  Group AstraZeneca (Group)
  Predecessor Zeneca Group Plc
Product Industry pharmaceutical
Persons Person Soriot, Pascal (AstraZeneca 201210– CEO before Roche COO Pharma Div before Genentech CEO)
  Person 2 Dunoyer, Marc (AstraZeneca 201311– CFO joined 201303 as EVP Global Portfolio + Product Strategy before GSK)
     
Region Region Cambridge, Cambridgeshire
  Country United Kingdom (GB)
  Street 1 Francis Crick Avenue
Cambridge Biomedical Campus
  City CB2 0AA Cambridge, Cambridgeshire
    Address record changed: 2024-01-05
     
Basic data Employees I: 50,001 to 100,0 (2022-12-31)
  Currency USD
  Annual sales 44,351,000,000 (revenue, total, consolidated (2022) 2022-12-31)
  Profit 3,293,000,000 (2022-12-31)
  Cash 6,166,000,000 (2022-12-31)
     
    * Document for »About Section«: AstraZeneca plc. (11/29/22). "Press Release: AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy".
     
   
Record changed: 2024-05-05

Advertisement

Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x200px

More documents for AstraZeneca (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Sino Biological Symposium Antibody Engineering Leipzig 650x200px




» top